Alzenau, Germany

Karl Schönafinger



Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Karl Schönafinger

Introduction

Karl Schönafinger is a notable inventor based in Alzenau, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various cardiovascular diseases. With a total of 11 patents to his name, Schönafinger's work has had a considerable impact on medical science.

Latest Patents

One of Schönafinger's latest patents is focused on sulfur substituted sulfonylaminocarboxylic acid N-arylamides. This invention relates to valuable pharmaceutically active compounds that are effective in the therapy and prophylaxis of diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses, and atherosclerosis. The compounds are capable of modulating the body's production of cyclic guanosine monophosphate (cGMP), making them suitable for treating conditions associated with a disturbed cGMP balance. Additionally, he has developed acylated indanyl amines, which are also aimed at pharmaceutical applications.

Career Highlights

Throughout his career, Schönafinger has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in drug development.

Collaborations

Schönafinger has collaborated with notable colleagues such as Hartmut Strobel and Ursula Schindler. These partnerships have further enhanced his research and development efforts, leading to the successful creation of new pharmaceutical compounds.

Conclusion

Karl Schönafinger's innovative work in the pharmaceutical field has led to significant advancements in the treatment of cardiovascular diseases. His contributions, marked by 11 patents, continue to influence medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…